Prollenium Medical Technologies

What Prollenium Medical Technologies does

Prollenium Medical Technologies, founded in 2002 and headquartered in Richmond Hill, Ontario, manufactures and globally distributes hyaluronic acid (HA)-based dermal fillers and related aesthetic devices. Its product portfolio centers on three brands: Revanesse, a range of HA injectable dermal fillers; VAMP, an advanced skin rejuvenation technology launched in 2024; and SoftFil, a cannula brand acquired to extend the company's offerings into the injection delivery device category. Prollenium positions itself as the only manufacturer in North America providing end-to-end product development and manufacturing within a single ISO 13485:2016-certified, FDA-approved facility, supporting quality control and supply chain efficiency.

The company operates a hybrid go-to-market combining direct field sales to aesthetic practitioners with an authorized global distributor network, supplemented by three product-specific microsites (Revanesse.com, VAMP Aesthetics, SoftFil.com). Its primary customer segments are aesthetic practitioners, including dermatologists and plastic surgeons performing injectable treatments, and the distributors that supply them; end consumers are a secondary segment reached via practitioner channels. Pricing is not publicly disclosed and follows contact-based B2B transactions through direct sales and distributor channels.

Complementing the product business, Prollenium runs the PACE (Prollenium Advanced Clinical Education) program, a training ecosystem partnering with over 150 medical professionals to deliver in-clinic training, cadaver labs, full-day symposiums, and webinars. In April 2026, PACE was extended into a scalable digital format via the PACE Training & Education Portal developed with Harley Academy, incorporating AI-powered anatomy tools, personalized learning pathways, and the proprietary GEM evidence-based methodology, used as a relationship-building and product-adoption lever across the practitioner base.

Name

Prollenium Medical Technologies

Legal name

Prollenium Medical Technologies

Website

https://prollenium.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

101–250 employees

Short description

Prollenium Medical Technologies, founded 2002 in Richmond Hill, Canada, manufactures HA-based dermal fillers (Revanesse), skin rejuvenation technology (VAMP), and aesthetic cannulas (SoftFil) at an ISO 13485-certified, FDA-approved facility, selling globally to aesthetic practitioners and distributors via direct sales and training through the PACE program.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Devices

NAICS

Pharmaceutical Preparation Manufacturing (325412), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Medicinal Chemicals & Botanical Products (2833), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

akta.pro secondary industries

Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning) (CRABAKAI)

Keywords

• Dermal fillers
• Hyaluronic acid injectables
• Aesthetic cannulas
• Medical aesthetics manufacturing
• Skin rejuvenation devices

Headquarters

HQ city

Richmond Hill

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Aesthetic Product Sales: Prollenium generates revenue through the sale of medical aesthetic products including HA injectable dermal fillers (Revanesse), skin rejuvenation technology (VAMP), and aesthetic cannulas (SoftFil) to aesthetic practitioners and clinics. Revenue is derived from product sales to healthcare providers.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Prollenium Medical Technologies manufactures and sells hyaluronic acid (HA) based dermal fillers under the Revanesse brand, advanced skin rejuvenation technology under VAMP, and aesthetic cannulas under the SoftFil brand for use by aesthetic practitioners. The company complements its product portfolio with the PACE clinical education program, offering in-clinic training, cadaver labs, symposiums, webinars, and a digital education portal to train practitioners and drive product adoption.

Product overview

Prollenium Medical Technologies offers a portfolio of medical aesthetic products and services. The core product lineup includes Revanesse® (a full range of HA injectable dermal fillers), VAMP™ (advanced skin rejuvenation technology), and SoftFil® (aesthetic cannulas). These products are manufactured at the company's North American facility that provides end-to-end product development and manufacturing in one location. Complementing the product portfolio, the company operates PACE (Prollenium Advanced Clinical Education), an evidence-based training ecosystem that includes in-person training, cadaver labs, symposiums, webinars, and a digital education portal to support aesthetic practitioners in developing clinical and practice skills.

Differentiator

Problem solved

Functional benefit

Brands

• PACE: Prollenium Advanced Clinical Education - an evidence-based training ecosystem for medical aesthetics practitioners
• Revanesse®
• VAMP™
• SoftFil®

Products and services

• Revanesse® HA Injectables

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Harley AcademycoreStrategic or Co-development Partner · 15 April 2026Prollenium collaborated with Harley Academy to develop the PACE Training & Education Portal, a digital learning platform providing on-demand access to educational resources, AI-powered anatomy tools, clinical insights, and business development modules. The partnership extends Prollenium's in-person training programs into a scalable digital format.
• SoftFilcoreOEM/ Whitelabel/ Licensing PartnerProllenium acquired SoftFil, a leading brand of aesthetic cannulas designed to enhance safety, simplicity, and comfort for injectors. This acquisition expands Prollenium's product portfolio and manufacturing capabilities in the aesthetic devices space.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/prollenium
• Facebookfacebook.com/prollenium
• LinkedInlinkedin.com/company/prollenium
• Instagraminstagram.com/prollenium

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Prollenium Medical Technologies